SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-031495
Filing Date
2024-03-14
Accepted
2024-03-14 16:15:39
Documents
99
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K elvn-20231231.htm   iXBRL 10-K 2986025
2 EX-4.2 elvn-ex4_2.htm EX-4.2 19177
3 EX-10.3 elvn-ex10_3.htm EX-10.3 75748
4 EX-10.6 elvn-ex10_6.htm EX-10.6 43237
5 EX-10.7 elvn-ex10_7.htm EX-10.7 42991
6 EX-10.8 elvn-ex10_8.htm EX-10.8 43441
7 EX-10.9 elvn-ex10_9.htm EX-10.9 43803
8 EX-10.10 elvn-ex10_10.htm EX-10.10 43786
9 EX-10.11 elvn-ex10_11.htm EX-10.11 103687
10 EX-10.12 elvn-ex10_12.htm EX-10.12 103407
11 EX-10.13 elvn-ex10_13.htm EX-10.13 103398
12 EX-10.14 elvn-ex10_14.htm EX-10.14 103411
13 EX-10.15 elvn-ex10_15.htm EX-10.15 103404
14 EX-10.16 elvn-ex10_16.htm EX-10.16 47987
15 EX-21.1 elvn-ex21_1.htm EX-21.1 4561
16 EX-23.1 elvn-ex23_1.htm EX-23.1 2721
17 EX-31.1 elvn-ex31_1.htm EX-31.1 14467
18 EX-31.2 elvn-ex31_2.htm EX-31.2 14452
19 EX-32.1 elvn-ex32_1.htm EX-32.1 8929
20 EX-32.2 elvn-ex32_2.htm EX-32.2 8919
21 EX-97.1 elvn-ex97_1.htm EX-97.1 46387
22 GRAPHIC img251772460_0.jpg GRAPHIC 87335
23 GRAPHIC img251772460_1.jpg GRAPHIC 87335
24 GRAPHIC img251772460_2.jpg GRAPHIC 87335
  Complete submission text file 0000950170-24-031495.txt   12127424

Data Files

Seq Description Document Type Size
25 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT elvn-20231231.xsd EX-101.SCH 1353192
101 EXTRACTED XBRL INSTANCE DOCUMENT elvn-20231231_htm.xml XML 1628722
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39247 | Film No.: 24750339
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)